Cargando…

Compliance to Care Guidelines for Duchenne Muscular Dystrophy

BACKGROUND: International care guidelines for Duchenne muscular dystrophy (DMD) were published in 2010, but compliance in clinical practice is unknown. OBJECTIVE: The objective of our study was to compare real-world DMD care in Germany, Italy, the UK, and the US with the clinical recommendations. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landfeldt, Erik, Lindgren, Peter, Bell, Christopher F., Schmitt, Claude, Guglieri, Michela, Straub, Volker, Lochmüller, Hanns, Bushby, Katharine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746744/ https://www.ncbi.nlm.nih.gov/pubmed/26870664 http://dx.doi.org/10.3233/JND-140053

Ejemplares similares

Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)

The burden of Duchenne muscular dystrophy: An international, cross-sectional study
por: Landfeldt, Erik, et al.
Publicado: (2014)

Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study
por: Landfeldt, Erik, et al.
Publicado: (2015)

Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis
por: Landfeldt, Erik, et al.
Publicado: (2016)

Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2019)

Improving recognition of Duchenne muscular dystrophy: a retrospective case note review
por: van Ruiten, Henriette J A, et al.
Publicado: (2014)

Adult care for Duchenne muscular dystrophy in the UK
por: Rodger, Sunil, et al.
Publicado: (2014)

Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy
por: Burch, Peter M., et al.
Publicado: (2015)

Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis
por: Landfeldt, Erik, et al.
Publicado: (2020)

Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
por: Heslop, Emma, et al.
Publicado: (2021)

Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy
por: Zaharieva, Irina T., et al.
Publicado: (2013)

An update on Becker muscular dystrophy
por: Straub, Volker, et al.
Publicado: (2023)

Extending Life in Duchenne Muscular Dystrophy: Implications for Appraisals of Cost-Effectiveness
por: Landfeldt, Erik
Publicado: (2018)

Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
por: Rodger, Sunil, et al.
Publicado: (2012)

MON-LB050 Preliminary Results from the "Observational Study of Clinical Outcomes for Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy (DMD) (NCT 02571205)"
por: Wood, Claire, et al.
Publicado: (2019)

Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy?
por: Wood, Claire L, et al.
Publicado: (2023)

The impact of testosterone therapy on quality of life in adolescents with Duchenne muscular dystrophy
por: Wood, CL, et al.
Publicado: (2021)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

The importance of genetic diagnosis for Duchenne muscular dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2016)

Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies
por: Spitali, Pietro, et al.
Publicado: (2018)

New aspects on patients affected by dysferlin deficient muscular dystrophy
por: Klinge, Lars, et al.
Publicado: (2009)

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy
por: Signorelli, Mirko, et al.
Publicado: (2019)

Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy
por: Moreira, Sandra, et al.
Publicado: (2017)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
por: Chiu, Yen-Hui, et al.
Publicado: (2009)

Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis
por: Broomfield, Jonathan, et al.
Publicado: (2021)

Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy
por: Wood, C. L., et al.
Publicado: (2019)

Assisted Cough and Pulmonary Compliance in Patients with Duchenne Muscular Dystrophy
por: Kang, Seong Woong, et al.
Publicado: (2005)

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
por: Strandberg, Kristin, et al.
Publicado: (2020)

Measurement of salivary testosterone in adolescents and young men with Duchenne muscular dystrophy
por: Sahun, Yolanda Alins, et al.
Publicado: (2021)

Neurocognitive Profiles in Duchenne Muscular Dystrophy and Gene Mutation Site
por: D’Angelo, Maria Grazia, et al.
Publicado: (2011)

Imperatives for DUCHENNE MD: a Simplified Guide to Comprehensive Care for Duchenne Muscular Dystrophy
por: Kinnett, Kathi, et al.
Publicado: (2015)

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
por: Scaglioni, Dominic, et al.
Publicado: (2021)

Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants
por: van den Bergen, Janneke C, et al.
Publicado: (2015)

Prognostic indicators of disease progression in Duchenne muscular dystrophy: A literature review and evidence synthesis
por: Ferizovic, Nermina, et al.
Publicado: (2022)

Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations
por: Suárez-Calvet, Xavier, et al.
Publicado: (2023)

Costs of Illness of Spinal Muscular Atrophy: A Systematic Review
por: Landfeldt, Erik, et al.
Publicado: (2021)

Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
por: Hoffman, Eric P., et al.
Publicado: (2019)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ob9djhjv5g13k534sblp8t16lm